Image pharmaphorum Editor Deep Dive Why pharma needs honest patient dialogue Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience. Deep Dive Did cancer clinical trials stay on track at ASCO 2019? Chicago is recovering after 40,000 oncologists and cancer experts descended on the city for this year’s ASCO conference. Views & Analysis Getting patients round the virtual table If pharma wants to be truly patient-centric, it needs to be talking to patients. Views & Analysis Adapting for the future of oncology trials Advanced analytical solutions provider Cytel is at the forefront of rapid changes in oncology R&D. Load more results
Deep Dive Why pharma needs honest patient dialogue Astellas Pharma US president Percival Barretto-Ko talks with Dr Paul Tunnah about drug pricing, collaboration and improving the patient experience.
Deep Dive Did cancer clinical trials stay on track at ASCO 2019? Chicago is recovering after 40,000 oncologists and cancer experts descended on the city for this year’s ASCO conference.
Views & Analysis Getting patients round the virtual table If pharma wants to be truly patient-centric, it needs to be talking to patients.
Views & Analysis Adapting for the future of oncology trials Advanced analytical solutions provider Cytel is at the forefront of rapid changes in oncology R&D.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
